DiaMedica to Present at the 17th Annual GCFF Conference in Toronto

MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 24, 2015) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced that Rick Pauls, President and CEO, is scheduled to present at the upcoming 17^th Annual Global Chinese Financial Forum (GCFF) Conference on Saturday September 26, 2015 at 2:55pm ET. The 2015 GCFF Conference will be held in Toronto, Courtyard by Marriott, Toronto Northeast/Markham.

About the GCFF Conference

The GCFF Toronto Conference, sponsored by NAI Interactive Ltd, is held on September 26, 2015 at the Courtyard by Marriott with corporate presentations in both English and Chinese for qualified Chinese investors. The event will feature tracks devoted to Life Sciences, Technology, Mining and Oil & Gas. The Conference will include corporate presentations and Q&A sessions, investor one-on-one meetings and networking opportunities.

About DiaMedica

DiaMedica is a publicly traded clinical stage biopharmaceutical company focused on developing novel treatments for stroke and other vascular diseases. DiaMedica's common shares are listed on the TSX Venture Exchange under the trading symbol "DMA" and on the OTCQB under the trading symbol "DMCAF".

FORWARD-LOOKING STATEMENTS

The statements made in this press release that are not historical facts contain forward -looking information that involves risk and uncertainties. All statements, other than statements of historical facts, which address DiaMedica's expectations, should be considered forward-looking statements. Such statements are based on management's exercise of business judgment as well as assumptions made by and information currently available to management. When used in this document, the words "may", "will", "anticipate", "believe", "estimate", "expect", "intend" and words of similar import, are intended to identify any forward -looking statements. You should not place undue reliance on these forward -looking statements. Forward looking statements in this news release include, but are not limited to, the Company's objectives, goals, future plans and statements regarding the use of proceeds from the private placement. Factors that could cause actual results to differ materially from such forward-looking information described in detail in the DiaMedica's filings with the Canadian securities regulators, all of which are available on SEDAR (www.sedar.com) . Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results could differ materially from those anticipated in these forward -looking statements. DiaMedica undertakes no obligation, and does not intend, to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of any unanticipated events, unless required by law. Although management believes that expectations are based on reasonable assumptions, no assurance can be given that these expectations will materialize.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the contents of this press release.